Linassi, Federico
Vide, Sergio
Ferreira, Ana
Schneider, Gerhard
Gambús, Pedro
Kreuzer, Matthias
Funding for this research was provided by:
Technische Universität München
Article History
Received: 2 August 2024
Accepted: 26 August 2024
First Online: 12 September 2024
Declarations
:
: Hospital CLINIC de Barcelona nº HCB/2016/0318v2.
: Each patient gave written consent.
: Matthias Kreuzer is named as an inventor for a patent dealing with spectral EEG features and age (U.S. Provisional Patent Application No. 62/914,183). Gerhard Schneider and Matthias Kreuzer are named as inventors for a patent filed on a novel method for intraoperative EEG monitoring (U.S. Patent Application Serial No. 62/960,947) and are also named as inventors for a patent dealing with the EEG features during anaesthesia emergence (U.S. Provisional Patent Application No. 63/459,294). Matthias Kreuzer received funding from Masimo Corporation, Narcotrend-Gruppe, Medtronic GmbH and Fresenius Kabi Deutschland GmbH for conducting EEG-based training for anaesthesiologists and received honoraria for speaking engagements related to the EEG.
: FL, SV, AF, GS, and MK declare no conflict of interest; PG was a co-developer of Q-NOX. He has received consulting fees from Quantium Medical.